Filter News

Medivation, Inc. Announces Participation At Upcoming Investor Conference

Published: Dec 18, 2014

SAN FRANCISCO, CA--(Marketwired - December 17, 2014) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • David Hung, M.D., president and chief executive officer will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 4:30pm PT at the Westin St. Francis Hotel, San Francisco, CA

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically-innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, visit www.medivation.com.


Contacts:
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900



Help employers find you! Check out all the jobs and post your resume.

Back to news